These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 34532483)
1. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma. Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483 [TBL] [Abstract][Full Text] [Related]
2. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma. Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of a m Zhao X; Cui L Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
5. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer. Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521 [TBL] [Abstract][Full Text] [Related]
6. m6A RNA methylation regulator-related signatures exhibit good prognosis prediction ability for head and neck squamous cell carcinoma. Zhai Y; Zheng L Sci Rep; 2022 Sep; 12(1):16358. PubMed ID: 36175504 [TBL] [Abstract][Full Text] [Related]
7. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma. Qi LW; Jia JH; Jiang CH; Hu JM Front Genet; 2020; 11():614566. PubMed ID: 33519919 [TBL] [Abstract][Full Text] [Related]
8. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma. Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S Front Oncol; 2020; 10():718. PubMed ID: 32547941 [TBL] [Abstract][Full Text] [Related]
9. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis. Miao C; Fang X; Chen Y; Zhao Y; Guo Q Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221 [TBL] [Abstract][Full Text] [Related]
10. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis. Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma. Xing Z; Xu Y; Xu X; Yang K; Qin S; Jiao Y; Wang L BMC Med Genomics; 2024 May; 17(1):137. PubMed ID: 38778403 [TBL] [Abstract][Full Text] [Related]
12. A Signature of N Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X Front Immunol; 2022; 13():809872. PubMed ID: 35185897 [TBL] [Abstract][Full Text] [Related]
13. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069 [TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer. Xu LC; Pan JX; Pan HD Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956 [TBL] [Abstract][Full Text] [Related]
15. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207 [TBL] [Abstract][Full Text] [Related]
16. Expression patterns and prognostic role of m6A RNA methylation regulators in Non-small Cell Lung Cancer. Zhang M; Yang C; Dong W; Zhao Y; Chen N; Gao C Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):67-72. PubMed ID: 38430042 [TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X Front Genet; 2022; 13():872186. PubMed ID: 35937991 [No Abstract] [Full Text] [Related]
18. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma. Wu X; Zhang X; Tao L; Dai X; Chen P Biomed Res Int; 2020; 2020():2053902. PubMed ID: 32733931 [TBL] [Abstract][Full Text] [Related]
19. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma. Shen C; Liu J; Yang X; Jiao W; Wang Y Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753 [TBL] [Abstract][Full Text] [Related]
20. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer. Jiao J; Jiang L; Luo Y Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]